Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 208 of the 209 references it cites were found in a registry or an index.

Metabolic origins and clinical significance of LDL heterogeneity

Open access
Berneis, Kaspar K., Krauss, Ronald M. · 2002 · Journal of Lipid Research

Abstract

LDLs in humans comprise multiple distinct subspecies that differ in their metabolic behavior and pathologic roles. Metabolic turnover studies suggest that this heterogeneity results from multiple pathways, including catabolism of different VLDL and IDL precursors, metabolic remodeling, and direct production. A common lipoprotein profile designated atherogenic lipoprotein phenotype is characterized by a predominance of small dense LDL particles. Multiple features of this phenotype, including increased levels of triglyceride rich lipoprotein remnants and IDLs, reduced levels of HDL and an association with insulin resistance, contribute to increased risk for coronary heart disease compared with individuals with a predominance of larger LDL. Increased atherogenic potential of small dense LDL is suggested by greater propensity for transport into the subendothelial space, increased binding to arterial proteoglycans, and susceptibility to oxidative modification. Large LDL particles also can be associated with increased coronary disease risk, particularly in the setting of normal or low triglyceride levels. Like small LDL, large LDL exhibits reduced LDL receptor affinity compared with intermediate sized LDL. Future delineation of the determinants of heterogeneity of LDL and other apoB-containing lipoproteins may contribute to improved identification and management of patients at high risk for atherosclerotic disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1194/jlr.r200004-jlr200

Cites

208 of 208 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 209 references

Research works printed but not linked: 9

  1. Alaupovic, 1992, The lipoprotein family concept and its clinical significance, Nutr. Metab. Cardiovasc. Dis., 2, 52
  2. Gofman, 1954, The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary artery disease, Plasma., 2, 413
  3. Krauss, 1995, Altered metabolism of large low density lipoproteins in subjects with predominance of small low density lipoproteins, Circulation., 92, I
  4. Blanche, 1999, Absence of hepatic lipase results in reduction of human-like small dense LDL in Fat-Fed human apoB Transgenic mice, Circulation., 100, A-13
  5. Blanche, 1995, Similar low density lipoprotein subclasses in fat-fed human-apoB transgenic mice and humans, Circulation., 92, I
  6. Olin, 1999, Apo CIII modulates lipoprotein binding to Vascular Proteoglycans, Circulation., 100, 3658
  7. Bu, 1992, Major gene control of atherogenic lipoprotein phenotype (ALP): a quantitative segregation analysis in 20 coronary artery disease (CAD) pedigrees, Am. J. Hum. Genet., 51, A336
  8. Miller, 1993, Baseline-triglyceride levels predict angiographic benefit of colestipol plus niacin therapy in the cholesterol-lowering atherosclerosis study (CLAS), Circulation., 4, I
  9. Miller, 1994, Predominance of mid-density low density lipoproteins predicts angiographic benefit of lovastatin in the monitored atherosclerosis regression study, Circulation., 90, I460

Cited by

See all 896

Metadata

Authors
Berneis, K. K., & Krauss, R. M.
Affiliations
Lawrence Berkeley National Laboratory (US)
Corresponding author
Krauss, Ronald M.
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2002-09
Volume
43
Issue
9
Pages
1363-1379
ISSN
0022-2275 (ISSN-L)
OpenAlex
W2009013500
Cited by
896
References
209
Citations by year
2026: 26 · 2025: 38 · 2024: 27 · 2023: 32 · 2022: 47 · 2021: 42 · 2020: 28 · 2019: 40 · 2018: 35 · 2017: 47 · 2016: 43 · 2015: 43 · 2014: 46 · 2013: 38 · 2012: 44
FWCI
4.43
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (5p01hl018574-26)
  • National Heart, Lung, and Blood Institute (HL-18574)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
small dense LDL, atherogenic lipoprotein phenotype, VLDL catabolism, IDL, HDL cholesterol, insulin resistance, coronary heart disease risk, oxidative modification, atherosclerosis, lipoprotein metabolism
MeSH terms
Coronary Artery Disease, Disease Susceptibility, Humans, Lipase, Lipoproteins, LDL, Phenotype

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic origins and clinical significance of LDL heterogeneity. https://app.cochat.ai/papers/10.1194/jlr.r200004-jlr200
The paper
Berneis, K. K., & Krauss, R. M. (2002). Metabolic origins and clinical significance of LDL heterogeneity. Journal of Lipid Research. https://doi.org/10.1194/jlr.r200004-jlr200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.